Method for treating or preventing emesis
AssigneeMerck Frosst Canada, Inc.
InventorAnnette Robichaud
Life of this patent
Estimating the term…
Abstract
Alpha-2 adrenoreceptor agonists are useful for the treatment and/or prevention of emesis in patients.
Claims15
A method for the treatment of emesis induced by a chemotherapeutic agent in a patient in need thereof which comprises administering to the patient an alpha-2 adrenoreceptor agonist, which is other than clonidine.
A method for the prevention of emesis induced by a chemotherapeutic agent in a patient in need thereof which comprises administering to the patient an alpha-2 adrenoreceptor agonist, which is other than clonidine.
A method for ameliorating the symptoms attendant to emesis induced by a chemotherapeutic agent in a patient comprising administering to the patient in need thereof an alpha-2 adrenoreceptor agonist, which is other than clonidine.
A method for the prevention of emesis induced by a chemotherapeutic agent in a patient in need thereof which comprises administering to the patient an alpha-2 adrenoreceptor agonist, which is other than clonidine, and an antiemetic agent.
Dependencies are inferred from the claim text.